NovoCure
NVCR
NVCR
197 hedge funds and large institutions have $4.17B invested in NovoCure in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 57 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
-3
Holders Change %
-1.5%
% of All Funds
4.29%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
33
Increased
84
Reduced
57
Closed
31
Calls
$88.2M
Puts
$28.7M
Net Calls
+$59.5M
Net Calls Change
+$5.98M
Top Buyers
1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$558M |
2 |
BlackRock
New York
|
$351M |
3 |
Nuveen Asset Management
Chicago,
Illinois
|
$30.9M |
4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$149M |
5 |
Invesco
Atlanta,
Georgia
|
$37.9M |